Holli Kawadler, PhD

Job title:

Research officer

Organization:

Michael J. Fox Foundation for Parkinson's Research (MJFF)

Technology:

molecular biology

PD Guide Terms:

PARK1/4 (SNCA/Alpha-Synuclein)

Targeting Pathogenic Mechanisms

Neuroimmune Signaling Pathways

Pathogenic Mechanisms

Protein Degradation Pathways

Neuroimmune Function

Programmed Cell Death

Investigative Tools

The Business of Science

Contributions:

Published Contributions:

Safinamide Clinical Trials from our Database

response to:

3 Jun 2009 12:08 PM EST

In response to this recent news report, here is the listing of clinical trials involving safinamide from our Clinical Trials Database: ...

Hsp70 may link parkin activity to alpha-synuclein aggregation

response to: Protein Misfolding & Aggregation

10 Mar 2009 10:29 AM EST

Expression of Hsp70 was shown to prevent dopaminergic neuronal loss associated with alpha-synuclein in Drosophila and interference with endogenous chaperone activity accelerated alpha-synuclein toxicity. ...

MJFF-funded work Targeting Excitotoxicity

response to: Targeting Excitotoxicity

7 Apr 2009 02:28 PM EST

MJFF is funding "A Pilot Phase II Double-blind, Placebo-controlled, Dosage Fi ...

Workgroups: